Pharmac funds another ADHD medicine to improve supply
Source: PHARMAC Pharmac will fund another brand of methylphenidate to help improve supply and provide more treatment options for people with attention deficit hyperactivity disorder (ADHD). The Rubifen LA (long-acting) brand of methylphenidate will be funded for people with ADHD. It is a generic version of the already funded Ritalin LA brand and will be…